These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7589212)

  • 1. PCA-4248, a PAF receptor antagonist, inhibits PAF-induced phosphoinositide turnover.
    Catalán RE; Martínez AM; Aragonés MD; Lombardía M; Garde E
    Eur J Pharmacol; 1995 Aug; 290(3):183-8. PubMed ID: 7589212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF and thrombin actions in platelets are selectively affected by a new 1,4-dihydropyridine derivative.
    Catalán RE; Martínez AM; Aragonés MD; Garde E; Lombardía M; Ortega P
    J Biochem; 1993 Apr; 113(4):450-5. PubMed ID: 8390447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.
    Nunez D; Randon J; Gandhi C; Siafaka-Kapadai A; Olson MS; Hanahan DJ
    J Biol Chem; 1990 Oct; 265(30):18330-8. PubMed ID: 2170407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies.
    Fernández-Gallardo S; Ortega MP; Priego JG; de Casa-Juana MF; Sunkel C; Sánchez Crespo M
    J Pharmacol Exp Ther; 1990 Oct; 255(1):34-9. PubMed ID: 2170626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Alkyl-1,4-dihydropyridines derivatives as specific PAF-acether antagonists.
    Sunkel CE; de Casa-Juana MF; Santos L; Gómez MM; Villarroya M; González-Morales MA; Priego JG; Ortega MP
    J Med Chem; 1990 Dec; 33(12):3205-10. PubMed ID: 2175357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
    Shukla SD; Morrison WJ; Dhar A
    Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
    Dhar A; Paul AK; Shukla SD
    Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to platelet-activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity.
    Shukla SD; Morrison WJ; Klachko DM
    Transfusion; 1989; 29(6):528-33. PubMed ID: 2546298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
    Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
    J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil inhibits phosphatidic acid formation and modifies phosphoinositide metabolism in stimulated platelets.
    Homa ST; Khan SN; Conroy DM; Speak AE; Smith AD
    Eur J Pharmacol; 1990 Jul; 182(3):457-64. PubMed ID: 2171946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
    Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of the PAF receptor antagonist, PCA 4248, with the rat pleurisy evoked by inflammatory mediators or allergen.
    Martins MA; Lima MC; Bozza PT; Faria Neto HC; Silva PM; Sunkel CE; Cordeiro RS
    Eur J Pharmacol; 1993 Jun; 237(1):17-22. PubMed ID: 8395390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
    Hwang SB; Lee CS; Cheah MJ; Shen TY
    Biochemistry; 1983 Sep; 22(20):4756-63. PubMed ID: 6313047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    Morrison WJ; Shukla SD
    J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.